FDA targets bioidentical hormone providers
News TargetPosted: January 30th, 2008 by Steve Trinward
“Early January, the U.S. Food and Drug Administration sent warnings to seven compounding pharmacies distributing the hormone estriol — a weak estrogen found in the human body — to patients whose doctors have deemed it safer and more appropriate than FDA approved synthetic versions of the hormone. Compounding is a process in which a pharmacist responds to a doctor’s prescription by tailoring a drug to meet the patient’s unique needs. In some cases a patient might be allergic to a specific dye or other additive, where in this case a patient would not be expected to respond well to a synthetic version of estrogen.” (01/30/08)
